60 DEGREES PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
35 Contracts & Agreements
- Description of the Registrants' Securities (Filed With SEC on April 1, 2024)
- Board of Directors Agreement dated as of December 15, 2022, as amended, by and between the Registrant and Paul Field (Filed With SEC on June 8, 2023)
- Board of Directors Agreement dated as of December 9, 2022, as amended, by and between the Registrant and Cheryl Xu (Filed With SEC on June 8, 2023)
- Board of Directors Agreement dated as of November 28, 2022, as amended, by and between the Registrant and Stephen Toovey (Filed With SEC on June 8, 2023)
- Board of Directors Agreement dated as of November 28, 2022, as amended, by and between the Registrant and Charles Allen (Filed With SEC on June 8, 2023)
- Note Extension Agreement dated as of May 18, 2023, by and between the Registrant and Mountjoy Trust (Filed With SEC on June 1, 2023)
- Note Extension Agreement dated as of May 18, 2023, by and between the Registrant and the Geoffrey S. Dow Revocable Trust (Filed With SEC on June 1, 2023)
- Note Extension Agreement dated as of May 22, 2023, by and between the Registrant and Walleye Opportunities Master Fund Ltd (Filed With SEC on June 1, 2023)
- Note Extension Agreement dated as of May 22, 2023, by and between the Registrant and Cavalry Investment Fund, LP (Filed With SEC on June 1, 2023)
- Note Extension Agreement dated as of May 22, 2023, by and between the Registrant and Bigger Capital Fund, LP (Filed With SEC on June 1, 2023)
- Form of Common Stock Purchase Warrant to be issued by the Registrant to WallachBeth Capital LLC (Filed With SEC on June 1, 2023)
- Common Stock Purchase Warrant dated as of May 8, 2023, issued by the Registrant to Sabby Volatility Warrant Master Fund, Ltd (Filed With SEC on June 1, 2023)
- Form of Underwriting Agreement (Filed With SEC on June 1, 2023)
- Agreement to Convert Debt to Equity dated as of August 31, 2021, issued by the Registrant to Douglas Loock (Filed With SEC on April 28, 2023)
- Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Tyrone Miller (Filed With SEC on April 28, 2023)
- Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Geoffrey Dow (Filed With SEC on April 28, 2023)
- Agreement to Consolidate and Convert Existing Debt dated as of December 31, 2021, between the Registrant and Geoffrey Dow (Filed With SEC on April 28, 2023)
- Master Consultancy Agreement dated as of May 29, 2013, by and between the Registrant and BioIntelect Pty Ltd (Filed With SEC on April 28, 2023)
- Inter-Institutional Agreement dated as of February 15, 2021, by the Registrant and Florida State University Research Foundation (Filed With SEC on April 28, 2023)
- Second Amendment to The Debt Conversion Agreement dated as of January 27, 2023, by and between the Registrant to Knight Therapeutics International S.A (Filed With SEC on April 28, 2023)
- First Amendment to the Debt Conversion Agreement dated as of January 19, 2023, by and between the Registrant to Knight Therapeutics International S.A (Filed With SEC on April 28, 2023)
- Debt Conversion Agreement dated as of January 9, 2023, by and between the Registrant to Knight Therapeutics International S.A (Filed With SEC on April 28, 2023)
- Agreement to Convert Debt to Equity dated as of August 31, 2021, issued by the Registrant to Douglas Loock (Filed With SEC on April 3, 2023)
- Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Tyrone Miller (Filed With SEC on April 3, 2023)
- Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Geoffrey Dow (Filed With SEC on April 3, 2023)
- Agreement to Consolidate and Convert Existing Debt dated as of December 31, 2021, between the Registrant and Geoffrey Dow (Filed With SEC on April 3, 2023)
- Master Consultancy Agreement dated as of May 29, 2013, by and between the Registrant and BioIntelect Pty Ltd (Filed With SEC on April 3, 2023)
- Inter-Institutional Agreement dated as of February 15, 2021, by the Registrant and Florida State University Research Foundation (Filed With SEC on April 3, 2023)
- Second Amendment to The Debt Conversion Agreement dated as of January 27, 2023, by and between the Registrant to Knight Therapeutics International S.A (Filed With SEC on April 3, 2023)
- First Amendment to the Debt Conversion Agreement dated as of January 19, 2023, by and between the Registrant to Knight Therapeutics International S.A (Filed With SEC on April 3, 2023)
- Debt Conversion Agreement dated as of January 9, 2023, by and between the Registrant to Knight Therapeutics International S.A (Filed With SEC on April 3, 2023)
- Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Tyrone Miller (Filed With SEC on January 31, 2023)
- Agreement to Convert Debt to Equity dated as of December 31, 2021, issued by the Registrant to Geoffrey Dow (Filed With SEC on January 31, 2023)
- Agreement to Consolidate and Convert Existing Debt dated as of December 31, 2021, between the Registrant and Geoffrey Dow (Filed With SEC on January 31, 2023)
- Inter-Institutional Agreement dated as of February 15, 2021, by the Registrant and Florida State University Research Foundation (Filed With SEC on January 31, 2023)